Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2016First federal award
$3.5MFederal grants as PI4 awards
1Patents grantedLatest Mar 23, 2021
146Papers3,830 citations
Federal awards and patents by year
AwardsPatents
4 awards · $3.5M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 15, 2021 | NIH | SBIR Phase II Development of a novel analgesic for mixed inflammatory and neuropathic pain states | $1.7M | AnaBios Corp |
| Sep 15, 2021 | NIH | SBIR Phase II Development of a novel analgesic for mixed inflammatory and neuropathic pain states | $1.7M | ANABIOS CORPORATION |
| Sep 15, 2020 | NIH | SBIR Phase I Development of a novel translational pain-drug screening platform for the generation of human-relevant data in preclinical pain drug discovery | $320K | AnaBios Corp |
| Sep 15, 2020 | NIH | SBIR Phase I Development of a novel translational pain-drug screening platform for the generation of human-relevant data in preclinical pain drug discovery | $320K | ANABIOS CORPORATION |
| Jun 23, 2017 | NIH | SBIR Phase II Validation and qualification of an ex vivo human cardiac tissue-based assay for the assessment of the potential cardiotoxicity of pharmaceutical compounds | $550K | AnaBios Corp |
| Jun 23, 2017 | NIH | SBIR Phase II Validation and qualification of an ex vivo human cardiac tissue-based assay for the assessment of the potential cardiotoxicity of pharmaceutical compounds | $550K | ANABIOS CORPORATION |
| Jul 7, 2016 | NIH | SBIR Phase II Validation and qualification of an ex vivo human cardiac tissue-based assay for the assessment of the potential cardiotoxicity of pharmaceutical compounds | $945K | AnaBios Corp |
| Jul 7, 2016 | NIH | SBIR Phase II Validation and qualification of an ex vivo human cardiac tissue-based assay for the assessment of the potential cardiotoxicity of pharmaceutical compounds | $945K | ANABIOS CORPORATION |
2 patents as inventor
- US 10955409AnaBios CorpMar 23, 2021
- US AnaBios Corp—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#509
Awards as PI#643
Patents#284
Companies
- AnaBios CorpLeads (SEC Form D)
- ANABIOS CORPORATIONLeads (SEC Form D) · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.